Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3335420 | Transfusion and Apheresis Science | 2011 | 4 Pages |
Abstract
The outcome for patients with diffuse large B-cell lymphomas improved dramatically in the last decade, and the opportunity for improving therapy for patients with peripheral T-cell lymphoma exists as we begin to study specific subtypes of the disease. It is entirely possible that patients with different genetic subtypes of diffuse large B-cell lymphoma will eventually require different treatments, and the same will be true for patients with subtypes of peripheral T-cell lymphoma. These possibilities will be the focus of clinical investigation over the next decade.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
James O. Armitage,